378 related articles for article (PubMed ID: 25581526)
21. How sugars protect proteins in the solid state and during drying (review): Mechanisms of stabilization in relation to stress conditions.
Mensink MA; Frijlink HW; van der Voort Maarschalk K; Hinrichs WL
Eur J Pharm Biopharm; 2017 May; 114():288-295. PubMed ID: 28189621
[TBL] [Abstract][Full Text] [Related]
22. Is vitrification sufficient to preserve liposomes during freeze-drying?
Crowe JH; Leslie SB; Crowe LM
Cryobiology; 1994 Aug; 31(4):355-66. PubMed ID: 7523026
[TBL] [Abstract][Full Text] [Related]
23. Effects of additives on the stability of Humicola lanuginosa lipase during freeze-drying and storage in the dried solid.
Kreilgaard L; Frokjaer S; Flink JM; Randolph TW; Carpenter JF
J Pharm Sci; 1999 Mar; 88(3):281-90. PubMed ID: 10052984
[TBL] [Abstract][Full Text] [Related]
24. A specific molar ratio of stabilizer to protein is required for storage stability of a lyophilized monoclonal antibody.
Cleland JL; Lam X; Kendrick B; Yang J; Yang TH; Overcashier D; Brooks D; Hsu C; Carpenter JF
J Pharm Sci; 2001 Mar; 90(3):310-21. PubMed ID: 11170024
[TBL] [Abstract][Full Text] [Related]
25. Effects of types of sugar on the stabilization of protein in the dried state.
Imamura K; Ogawa T; Sakiyama T; Nakanishi K
J Pharm Sci; 2003 Feb; 92(2):266-74. PubMed ID: 12532376
[TBL] [Abstract][Full Text] [Related]
26. Freeze-drying of proteins with glass-forming oligosaccharide-derived sugar alcohols.
Kadoya S; Fujii K; Izutsu K; Yonemochi E; Terada K; Yomota C; Kawanishi T
Int J Pharm; 2010 Apr; 389(1-2):107-13. PubMed ID: 20097277
[TBL] [Abstract][Full Text] [Related]
27. Investigation of the stabilisation of freeze-dried lysozyme and the physical properties of the formulations.
Liao YH; Brown MB; Martin GP
Eur J Pharm Biopharm; 2004 Jul; 58(1):15-24. PubMed ID: 15207533
[TBL] [Abstract][Full Text] [Related]
28. Physical characterisation of formulations for the development of two stable freeze-dried proteins during both dried and liquid storage.
Passot S; Fonseca F; Alarcon-Lorca M; Rolland D; Marin M
Eur J Pharm Biopharm; 2005 Aug; 60(3):335-48. PubMed ID: 15894475
[TBL] [Abstract][Full Text] [Related]
29. Optimizing storage stability of lyophilized recombinant human interleukin-11 with disaccharide/hydroxyethyl starch mixtures.
Garzon-Rodriguez W; Koval RL; Chongprasert S; Krishnan S; Randolph TW; Warne NW; Carpenter JF
J Pharm Sci; 2004 Mar; 93(3):684-96. PubMed ID: 14762907
[TBL] [Abstract][Full Text] [Related]
30. Beta-relaxation of insulin molecule in lyophilized formulations containing trehalose or dextran as a determinant of chemical reactivity.
Yoshioka S; Miyazaki T; Aso Y
Pharm Res; 2006 May; 23(5):961-6. PubMed ID: 16715386
[TBL] [Abstract][Full Text] [Related]
31. Investigations into the stabilization of drugs by sugar glasses: III. The influence of various high-pH buffers.
Eriksson JH; Hinrichs WL; de Jong GJ; Somsen GW; Frijlink HW
Pharm Res; 2003 Sep; 20(9):1437-43. PubMed ID: 14567639
[TBL] [Abstract][Full Text] [Related]
32. Systematic investigation of the effect of lyophilizate collapse on pharmaceutically relevant proteins III: collapse during storage at elevated temperatures.
Schersch K; Betz O; Garidel P; Muehlau S; Bassarab S; Winter G
Eur J Pharm Biopharm; 2013 Oct; 85(2):240-52. PubMed ID: 23727369
[TBL] [Abstract][Full Text] [Related]
33. Stability and plasticizing and crystallization effects of vitamins in amorphous sugar systems.
Zhou Y; Roos YH
J Agric Food Chem; 2012 Feb; 60(4):1075-83. PubMed ID: 22220563
[TBL] [Abstract][Full Text] [Related]
34. Thermal Gradient Mid- and Far-Infrared Spectroscopy as Tools for Characterization of Protein Carbohydrate Lyophilizates.
Mensink MA; Šibík J; Frijlink HW; van der Voort Maarschalk K; Hinrichs WLJ; Zeitler JA
Mol Pharm; 2017 Oct; 14(10):3550-3557. PubMed ID: 28874050
[TBL] [Abstract][Full Text] [Related]
35. Is trehalose special for preserving dry biomaterials?
Crowe LM; Reid DS; Crowe JH
Biophys J; 1996 Oct; 71(4):2087-93. PubMed ID: 8889183
[TBL] [Abstract][Full Text] [Related]
36. Freeze drying of nanosuspensions, 2: the role of the critical formulation temperature on stability of drug nanosuspensions and its practical implication on process design.
Beirowski J; Inghelbrecht S; Arien A; Gieseler H
J Pharm Sci; 2011 Oct; 100(10):4471-81. PubMed ID: 21607957
[TBL] [Abstract][Full Text] [Related]
37. Stability of buffer-free freeze-dried formulations: A feasibility study of a monoclonal antibody at high protein concentrations.
Garidel P; Pevestorf B; Bahrenburg S
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):125-39. PubMed ID: 26455339
[TBL] [Abstract][Full Text] [Related]
38. Manufacturing and ambient stability of shelf freeze dried bacteriophage powder formulations.
Zhang Y; Peng X; Zhang H; Watts AB; Ghosh D
Int J Pharm; 2018 May; 542(1-2):1-7. PubMed ID: 29486286
[TBL] [Abstract][Full Text] [Related]
39. Freeze-drying of nanosuspensions, part 3: investigation of factors compromising storage stability of highly concentrated drug nanosuspensions.
Beirowski J; Inghelbrecht S; Arien A; Gieseler H
J Pharm Sci; 2012 Jan; 101(1):354-62. PubMed ID: 21905035
[TBL] [Abstract][Full Text] [Related]
40. Freeze-dried snake antivenoms formulated with sorbitol, sucrose or mannitol: comparison of their stability in an accelerated test.
Herrera M; Tattini V; Pitombo RN; Gutiérrez JM; Borgognoni C; Vega-Baudrit J; Solera F; Cerdas M; Segura A; Villalta M; Vargas M; León G
Toxicon; 2014 Nov; 90():56-63. PubMed ID: 25091348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
